Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1973 2
1975 1
1976 1
1978 1
1985 1
1990 2
1991 2
1992 2
1994 1
1999 1
2000 2
2008 1
2009 1
2011 4
2012 2
2013 3
2014 2
2015 2
2016 2
2018 4
2019 1
2020 7
2021 8
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.
Favorskaya IA, Shcheblyakov DV, Esmagambetov IB, Dolzhikova IV, Alekseeva IA, Korobkova AI, Voronina DV, Ryabova EI, Derkaev AA, Kovyrshina AV, Iliukhina AA, Botikov AG, Voronina OL, Egorova DA, Zubkova OV, Ryzhova NN, Aksenova EI, Kunda MS, Logunov DY, Naroditsky BS, Gintsburg AL. Favorskaya IA, et al. Among authors: kunda ms. Front Immunol. 2022 Feb 24;13:822159. doi: 10.3389/fimmu.2022.822159. eCollection 2022. Front Immunol. 2022. PMID: 35281053 Free PMC article.
COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho.
Andom AT, Asfaw M, Maama-Maime LB, Kunda M, Mpinda S, Mukherjee J, Ndayizigiye M, Sheyo N, Zulu M, Mitnick CD, Seung KJ. Andom AT, et al. Among authors: kunda m. Am J Trop Med Hyg. 2023 Oct 9;109(5):1205-1206. doi: 10.4269/ajtmh.23-0422. Am J Trop Med Hyg. 2023. PMID: 37918004 Free PMC article. No abstract available.
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Patil SB, Tamirat M, Khazhidinov K, Ardizzoni E, Atger M, Austin A, Baudin E, Bekhit M, Bektasov S, Berikova E, Bonnet M, Caboclo R, Chaudhry M, Chavan V, Cloez S, Coit J, Coutisson S, Dakenova Z, De Jong BC, Delifer C, Demaisons S, Do JM, Dos Santos Tozzi D, Ducher V, Ferlazzo G, Gouillou M, Khan U, Kunda M, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moreau M, Moschioni M, Nahid P, Osso E, Oyewusi L, Panda S, Pâquet A, Thuong Huu P, Pichon L, Rich ML, Rupasinghe P, Salahuddin N, Sanchez Garavito E, Seung KJ, Velásquez GE, Vallet M, Varaine F, Yuya-Septoh FJ, Mitnick CD, Guglielmetti L. Patil SB, et al. Among authors: kunda m. Trials. 2023 Nov 30;24(1):773. doi: 10.1186/s13063-023-07701-6. Trials. 2023. PMID: 38037119 Free PMC article.
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection.
Esmagambetov IB, Shcheblyakov DV, Egorova DA, Voronina OL, Derkaev AA, Voronina DV, Popova O, Ryabova EI, Shcherbinin DN, Aksenova EI, Semenov AN, Kunda MS, Ryzhova NN, Zubkova OV, Tukhvatulin AI, Logunov DY, Naroditsky BS, Borisevich SV, Gintsburg AL. Esmagambetov IB, et al. Among authors: kunda ms. Acta Naturae. 2021 Oct-Dec;13(4):53-63. doi: 10.32607/actanaturae.11487. Acta Naturae. 2021. PMID: 35127147 Free PMC article.
65 results